Does Advoy.com™ help patients with primary immunodeficiency diseases experience that their life situation has improved?
DOI:
https://doi.org/10.3395/reciis.v4i2.675Keywords:
primary immunodeficiency diseases, home therapy, life situation, advoy, qualitative, content analysisAbstract
Lifelong immunoglobulin therapy for patients with primary immunodeficiency diseases are more often provided at home. We explored the impact of living with a chronic disease, the life situation as well as using Advoy, a new web-based patient diary with messaging function. Twelve adults from Sweden wrote an essay each about their disease and how it is to be an Advoy user. The text was analyzed with directed qualitative content analysis. The respondents stated that they were living on a border; hence their lives were much better after starting their home therapy. Using Advoy made them feel more confident, since the overview and history of their treatment gave them information and understanding about their problems. It was hard to navigate on the Advoy site, and this made some of the respondents frustrated, so they used it only for plain treatment documentation. Improvements are needed in Advoy, in order to enhance self care activities.Downloads
Published
How to Cite
Issue
Section
License
Author’s rights: The author retains unrestricted rights over his work.
Rights to reuse: Reciis adopts the Creative Commons License, CC BY-NC non-commercial attribution according to the Policy on Open Access to Knowledge by Oswaldo Cruz Foundation. With this license, access, download, copy, print, share, reuse, and distribution of articles is allowed, provided that it is for non-commercial use and with source citation, granting proper authorship credits and reference to Reciis. In such cases, no permission is required from the authors or editors.
Rights of authors’s deposit / self-archiving: The authors are encouraged to deposit the published version, along with the link of their article in Reciis, in institutional repositories.